KORU Medical Systems, Inc. (KRMD)
(Delayed Data from NSDQ)
$4.16 USD
+0.12 (2.97%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $4.17 +0.01 (0.24%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
KRMD 4.16 +0.12(2.97%)
Will KRMD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for KRMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for KRMD
Are You Looking for a Top Momentum Pick? Why KORU Medical Systems, Inc. (KRMD) is a Great Choice
KORU Medical Systems, Inc. (KRMD) Reports Break-Even Earnings for Q2
KRMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
American Well Corporation (AMWL) Reports Q2 Loss, Beats Revenue Estimates
Omnicell (OMCL) Beats Q2 Earnings and Revenue Estimates
KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates
Other News for KRMD
Craig-Hallum Reaffirms Their Buy Rating on REPRO-MED Systems (KRMD)
Is KRMD consolidating before a move? Bollinger Band Squeeze shows up after rising 2.02%
REPRO-MED Systems (KRMD) Receives a Buy from Canaccord Genuity
Lake Street Reaffirms Their Buy Rating on REPRO-MED Systems (KRMD)
Koru Medical (KRMD) Partners with ForCast Orthopedics for Infection Treatment